Launched probiotics product of Union•Health series.
Determination Kit for Allergen Specific Anti-body IgE(CG) was approved by China Food and Drug Administration(CFDA).
Received the ‘Beijing Science and Technology Award, second prize’&’ Chinese Medical Science and Technology Award, third prize’ for the project ‘Diagnostic and therapeutic system & key technology for allergy’, which cooperated with PUMCH;
Obtained certificates of registration for the allergen products by SFDA.
Established the allergen standardization workshop in line with the GMP requirements, and obtained the drug production license by SFDA.
Obtained the only license of allergen hospital preparation in China.
The first national survey of airborne fungi in China.
Peking Union Medical College Hospital (PUMCH) started to research allergy and allergen preparation.
Determination Kit for Food Specific Anti-body IgG(CLIA) was approved by Beijing Food and Drug Administration(BFDA).
Determination Kit for Allergen Specific Anti-body IgE(CLIA) was approved by SFDA.
Certificated by ISO13485.
Identified as high-tech enterprises.
Approved by ministry of health and Chinese Academy of Medical Sciences, PUMCH and Macrolink Group cooperated to established ‘Beijing Macro-Union pharmaceutical Co.Ltd’ based on the allergen production & development center.
The establishment of allergen production & development center of PUMCH.
The first national survey of airborne pollen in China.
Launched probiotics product of Union•Health series.
Determination Kit for Food Specific Anti-body IgG(CLIA) was approved by Beijing Food and Drug Administration(BFDA).
Determination Kit for Allergen Specific Anti-body IgE(CG) was approved by China Food and Drug Administration(CFDA).
Determination Kit for Allergen Specific Anti-body IgE(CLIA) was approved by SFDA.
Received the ‘Beijing Science and Technology Award, second prize’&’ Chinese Medical Science and Technology Award, third prize’ for the project ‘Diagnostic and therapeutic system & key technology for allergy’, which cooperated with PUMCH;
Certificated by ISO13485.
Obtained certificates of registration for the allergen products by SFDA.
Identified as high-tech enterprises.
Established the allergen standardization workshop in line with the GMP requirements, and obtained the drug production license by SFDA.
Approved by ministry of health and Chinese Academy of Medical Sciences, PUMCH and Macrolink Group cooperated to established ‘Beijing Macro-Union pharmaceutical Co.Ltd’ based on the allergen production & development center.
Obtained the only license of allergen hospital preparation in China.
The establishment of allergen production & development center of PUMCH.
The first national survey of airborne fungi in China.
The first national survey of airborne pollen in China.
Peking Union Medical College Hospital (PUMCH) started to research allergy and allergen preparation.